"Prospective Research Innovations Inc. is the fastest growing medical research company in the U.S. The company was founded by Jamaica native, Omar Barnett. Mr. Barnett started with a staff of three and now Mr. Barnett oversees a staff of fifteen and his company is continuously growing to meet their sponsor’s needs. Some of the sponsors they work with are Johnson & Johnson, GlaxoSmithKline (GSK), Sanofi & AbbVie. Prospective Research Innovations Inc. is a multi-therapeutic facility, and they conduct clinical trials to advance medicine and give patients a better quality of life. They have an incredible team of expert physicians and investigators with over 20 years of experience."

During the past decade, Prospective Research Innovations Inc. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Prospective Research Innovations Inc." #1 sponsor was "InDex Pharmaceuticals" with 1 trials, followed by "Inventiva Pharma" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 1 trials sponsored and "Paradigm Biopharmaceuticals USA (INC)" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Prospective Research Innovations Inc." are "Depressive Disorder, Major" (1 trials), "NASH - Nonalcoholic Steatohepatitis" (1 trials), "Osteoarthritis of the Knee" (1 trials), "Osteoarthritis, Knee" (1 trials) and "Schizophrenia" (1 trials). Many other conditions were trialed in "Prospective Research Innovations Inc." in a lesser frequency.

Most popular intervention types in "Prospective Research Innovations Inc." are "Drug" (5 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Abilify MyCite®" (1 trials), "Cobitolimod 250 mg" (1 trials), "Cobitolimod 500 mg" (1 trials) and "DSP" (1 trials). Other intervention names were less common.

The vast majority of trials in "Prospective Research Innovations Inc." are 6 trials for "All" genders.

Currently, there are NaN active trials in "Prospective Research Innovations Inc.". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Prospective Research Innovations Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Prospective Research Innovations Inc., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".